Profitelligence provides financial data and analytics for informational purposes only. Nothing on this platform constitutes investment advice, a recommendation, or an offer to buy or sell any securities. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions.
By continuing, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.
You're browsing as a guest. Some features like watchlists and alerts require a free account.

CME Group Inc.
| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 09/09 | CME | 8-K | CME Group Announces New Senior Leadership Appointments | — | — | — |
| 08/11 | CME | 8-K | CME Group Announces Pricing Changes | — | — | — |
| 07/22 | CME | 8-K | CME Group Reports Strong Q2 2026 Financial Results | — | — | — |
| 06/17 | CME | 8-K | CME Group Announces Leadership Transition with Duffy to Executive Chairman and Fitzpatrick as New CEO | — | — | — |
| 06/10 | CME | 8-K | CME Group Inc. Annual Meeting Results: Director Election Proposals Fail, Amendment Passes | — | — | — |
| 05/19 | CME | 8-K | CME Group Inc. Announces Results of 2026 Annual Meeting of Shareholders | — | — | — |
| 04/27 | CME | 8-K | CME Group Inc. Amends $7 Billion Credit Facility | — | — | — |
| 04/22 | CME | 8-K | CME Group Reports Record Q1 2026 Financial Results | — | — | — |
| 02/04 | CME | 8-K | CME Group Reports Record Annual Revenue and Volume for 2025 | — | — | — |
| 02/02 | CME | 8-K | CME Group Communicates Pricing Changes to Clients | — | — | — |
| 10/22/25 | CME | 8-K | CME Group Reports Q3 2025 Financial Results with Adjusted Earnings Matching Prior Year | — | — | — |
| 09/11/25 | CME | 8-K | CME Group Announces Retirement of Chief Accounting Officer Jack Tobin | — | — | — |
| 07/25/25 | CME | 8-K | CME Group Wins Legal Battle Against Class B Shareholders | — | — | — |
| 07/23/25 | CME | 8-K | CME Group Inc. Reports Record Revenue and Earnings for Q2 2025 | — | — | — |
| 05/09/25 | CME | 8-K | CME Group Shareholders Re-elect Directors and Approve Compensation at 2025 Annual Meeting | — | — | — |
| 04/25/25 | CME | 8-K | CME Group Announces New Credit Facilities | — | — | — |
| 04/23/25 | CME | 8-K | CME Group Reports Record Q1 2025 Financials | — | — | — |
| 04/14/25 | CME | 8-K | CME Group to Sell Osttra for $3.1 Billion to KKR | — | — | — |
| 03/10/25 | CME | 8-K | CME Group Inc. Completes $750M Notes Offering | — | — | — |
| 03/04/25 | CME | 8-K | CME Group Announces $750M Bond Offering | — | — | — |
| 02/12/25 | CME | 8-K | CME Group Reports Record Annual Revenue and Earnings for 2024 | — | — | — |
| 12/11/24 | CME | 8-K | CME Group Inc. Announces Changes to Clearing House Collateral Fee Schedule and Pricing | — | — | — |
| 12/05/24 | CME | 8-K | CME Group Announces $3 Billion Share Repurchase Program and $2.1 Billion Annual Dividend | — | — | — |
| 11/07/24 | CME | 8-K | CME Group Extends Chairman and CEO's Employment Agreement, Announces Key Leadership Changes | — | — | — |
| 10/23/24 | CME | 8-K | CME Group Reports Record Financial Results for Q3 2024 | — | — | — |
| 07/24/24 | CME | 8-K | CME Group Reports Record Q2 2024 Financial Results | — | — | — |
| 07/08/24 | CME | 8-K | CME Group Appoints Mike Dennis as Global Head of Fixed Income, Dennis Resigns from Board | — | — | — |
| 05/13/24 | CME | 8-K | CME Group Inc. Announces Results of 2024 Annual Meeting of Shareholders | — | — | — |
| 04/25/24 | CME | 8-K | CME Group Inc. Announces Amendment to Credit Facility | — | — | — |
| 04/24/24 | CME | 8-K | CME Group Reports First-Quarter 2024 Financial Results with Adjusted Earnings Beat | — | — | — |
| 03/07/24 | CME | 8-K | CME Group Inc. Announces Amendments to Stock Plan | — | — | — |
| 02/14/24 | CME | 8-K | CME Group Reports Record Annual Results for 2023 with Strong Interest Rate Product Performance | — | — | — |
CME Group Inc. (CME): 32 8-K filings summarized, the most recent on Sep 9, 2026.
CME Group, the world's leading derivatives marketplace, announced new senior leadership appointments in its finance and legal divisions. Jack Tobin will be promoted to Chief Financial Officer, effective March 2027, after serving as Deputy Chief Financial Officer starting November 2026. Matthew Render will succeed…
CME Group Announces New Senior Leadership AppointmentsOn August 11, 2026, CME Group Inc. disclosed pricing changes to its clients via Special Executive Report No. 9799, as required under Regulation FD. A copy of this notice has been posted to the Company's website.
CME Group Announces Pricing ChangesCME Group Inc. reported strong financial results for the second quarter of 2026, with revenue of $1.7 billion, operating income of $1.1 billion, and net income of $1.0 billion. Diluted earnings per common share were $2.88 on a GAAP basis and $2.99 on an adjusted basis. The company also reported a record $238 million…
CME Group Reports Strong Q2 2026 Financial ResultsCME Group Inc. announced on June 17, 2026, that Terrence A. Duffy, its current Chairman and Chief Executive Officer, will transition to the role of Executive Chairman, effective March 1, 2027. Lynne C. Fitzpatrick, the current President and Chief Financial Officer, will succeed Duffy as the new Chief Executive Officer…
CME Group Announces Leadership Transition with Duffy to Executive Chairman and Fitzpatrick as New CEOCME Group Inc. held its 2026 Annual Meeting of Shareholders on June 9, 2026. Proposals to eliminate the right of Class B-1, B-2, and B-3 shareholders to elect directors did not pass. However, an amendment to the certificate of incorporation passed, though it will not be filed due to the failure of other proposals.…
CME Group Inc. Annual Meeting Results: Director Election Proposals Fail, Amendment Passes